These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3362368

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
    Kellar KJ, Whitehouse PJ, Martino-Barrows AM, Marcus K, Price DL.
    Brain Res; 1987 Dec 08; 436(1):62-8. PubMed ID: 3690354
    [Abstract] [Full Text] [Related]

  • 5. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
    Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, Perry RH, Perry EK.
    Neuroscience; 2000 Dec 08; 98(1):79-87. PubMed ID: 10858614
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.
    Aubert I, Araujo DM, Cécyre D, Robitaille Y, Gauthier S, Quirion R.
    J Neurochem; 1992 Feb 08; 58(2):529-41. PubMed ID: 1729398
    [Abstract] [Full Text] [Related]

  • 10. Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.
    Pimlott SL, Piggott M, Owens J, Greally E, Court JA, Jaros E, Perry RH, Perry EK, Wyper D.
    Neuropsychopharmacology; 2004 Jan 08; 29(1):108-16. PubMed ID: 12955099
    [Abstract] [Full Text] [Related]

  • 11. Selective cortical decrease of high-affinity choline uptake carrier in Alzheimer's disease: an autoradiographic study using 3H-hemicholinium-3.
    Rodríguez-Puertas R, Pazos A, Zarranz JJ, Pascual J.
    J Neural Transm Park Dis Dement Sect; 1994 Jan 08; 8(3):161-9. PubMed ID: 7748460
    [Abstract] [Full Text] [Related]

  • 12. Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases.
    Whitford C, Candy J, Edwardson J, Perry R.
    J Neurol Sci; 1988 Aug 08; 86(1):13-8. PubMed ID: 2902199
    [Abstract] [Full Text] [Related]

  • 13. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies.
    Perry DC, Dávila-García MI, Stockmeier CA, Kellar KJ.
    J Pharmacol Exp Ther; 1999 Jun 08; 289(3):1545-52. PubMed ID: 10336551
    [Abstract] [Full Text] [Related]

  • 14. Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease.
    Sugaya K, Giacobini E, Chiappinelli VA.
    J Neurosci Res; 1990 Nov 08; 27(3):349-59. PubMed ID: 2097379
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease.
    Schröder H, Giacobini E, Struble RG, Zilles K, Maelicke A.
    Neurobiol Aging; 1991 Nov 08; 12(3):259-62. PubMed ID: 1876232
    [Abstract] [Full Text] [Related]

  • 17. Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia.
    London ED, Ball MJ, Waller SB.
    Neurochem Res; 1989 Aug 08; 14(8):745-50. PubMed ID: 2812250
    [Abstract] [Full Text] [Related]

  • 18. Characterization of L-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal.
    Flynn DD, Mash DC.
    J Neurochem; 1986 Dec 08; 47(6):1948-54. PubMed ID: 3772387
    [Abstract] [Full Text] [Related]

  • 19. Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.
    Lehéricy S, Brandel JP, Hirsch EC, Anglade P, Villares J, Scherman D, Duyckaerts C, Javoy-Agid F, Agid Y.
    Brain Res; 1994 Oct 03; 659(1-2):1-9. PubMed ID: 7820649
    [Abstract] [Full Text] [Related]

  • 20. Extraneural cholinergic markers in Alzheimer's and Parkinson's disease.
    Adem A, Nordberg A, Bucht G, Winblad B.
    Prog Neuropsychopharmacol Biol Psychiatry; 1986 Oct 03; 10(3-5):247-57. PubMed ID: 3797683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.